Targeted Alpha-particle Nano-generator Actinium-225 (225 Ac)-lintuzumab (anti-CD33) in Acute Myeloid Leukemia (AML) by Jurcic, J.G, Rosenblat, T.L, McDevitt, M.R, Pandit-Taskar, N, Carrasquillo, J.A, Chanel, S.M, Zikaras, K, Frattini, M.G, Maslak, P.M, Cicic, D, Larson, S.M, Scheinberg, D.A

Get full text